Development of a high-throughput Alamar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca/ts phenotype

Journal of Virological Methods

Volumn 150, Issue 1-2, 2008, Pages 63-69

  Mo, Chengjun ^a   Yamagata, Ryan ^a   Pan, Alfred ^a   Reddy, Jhansi ^a   Hazari, Nisha ^a   Duke, Gregory ^a  

^a MEDIMMUNE   (United States)

Author keywords

Alamar blue; ca ts phenotype assay; Influenza virus; Microneutralization assay; TCID50 titer

Indexed keywords

ALAMAR BLUE; DYE; INFLUENZA VACCINE;

ANTIBODY TITER; ARTICLE; BIOASSAY; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPATHOGENIC EFFECT; DRUG DETERMINATION; FERRET; FLUORESCENCE; HIGH THROUGHPUT SCREENING; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS B; INTERMETHOD COMPARISON; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TEMPERATURE SENSITIVITY; TISSUE CULTURE; VIRUS NEUTRALIZATION; VIRUS TITRATION; WILD TYPE;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CELL SURVIVAL; CYTOPATHOGENIC EFFECT, VIRAL; DOGS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; NEUTRALIZATION TESTS; OXAZINES; REGRESSION ANALYSIS; STAINING AND LABELING; STATISTICS AS TOPIC; VIROLOGY; XANTHENES;

ORTHOMYXOVIRIDAE;

EID: 42649137855     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.03.006     Document Type: Article

References (28)

1. 3H]thymidine incorporation assay. J. Immunol. Methods 170 (1994) 211-224
2. Al-Nasiry S., Geusens N., Hanssens M., Luyten C., and Pijnenborg R. The use of Alamar blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum. Reprod. (2007) 1304-1309
3. Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P., Bernstein D.I., Hayden F.G., Kotloff K., Zangwill K., Iacuzio D., and Wolff M. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N. Engl. J. Med. 338 (1998) 1405-1412
4. Cianci C., Yu K.-L., Combrink K., Sin N., Pearce B., Wang A., Civiello R., Voss S., Luo G., Kadow K., Genovesi E.V., Venables B., Gulgeze H., Trehan A., James J., Lamb L., Medina I., Roach J., Yang Z., Zadjura L., Colonno R., Clark J., Meanwell N., and Krystal M. Orally active fusion inhibitor of respiratory syncytial virus. Antimicrob. Agents Chemother. 48 (2004) 413-422
5. Collins L.A., and Franzblau S.G. Microplate Alamar Blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41 (1997) 1004-1009
6. da Silva P.A., Boffo M.M.S., de Mattos I.G., Silva A.B.S., Palomino J.C., Martin A., and Takiff H.E. Comparison of redox and D29 phage methods for detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis. Clin. Microbiol. Infect. 12 (2006) 293-296
7. Dushoff J., Plotkin J.B., Viboud C., Earn D.J.D., and Simonsen L. Mortality due to influenza in the United States-an annualized regression approach using multiple-cause mortality data. Am. J. Epidemiol. 163 (2006) 181-187
8. Giannini C., Caini P., Giannelli F., Fontana F., Kremsdorf D., Brechot C., and Zignego A.L. Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways. J. Gen. Virol. 83 (2002) 1665-1671
9. Giffin K., Rader R.K., Marino M.H., and Forgey R.W. Novel assay for the influenza virus M2 channel activity. FEBS Lett. 357 (1995) 269-274
10. Hamid R., Rotshteyn Y., Rabadi L., Parikh R., and Bullock P. Comparison of Alamar blue and MTT assays for high through-put screening. Toxicol. In Vitro 18 (2004) 703-710
11. Ieong M.H., Reardon C.C., Levitz S.M., and Kornfeld H. Human immunodeficiency virus type 1 infection of alveolar macrophages impairs their innate fungicidal activity. Am. J. Respir. Crit. Care Med. 162 (2000) 966-970
12. Jarousse N., Syan S., Martinat C., and Brahic M. The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability to infect cultured neurons. J. Virol. 72 (1998) 7213-7220
13. Kauffman C.A., and Zarins L.T. Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species. Mycoses 42 (1999) 539-542
14. LaBarre D.D., and Lowy R.J. Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays. J. Virol. Methods 96 (2001) 107-126
15. Lancaster, M.V., Fields, R.D., 1996. Antibiotic and cytotoxic drug susceptibility testing using resazurin and poising agents, U.S. Patent 5,501,959.
16. Maassab H.F., Kendal A.P., Abrams G.D., and Monto A.S. Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J. Infect. Dis. 146 (1982) 780-790
17. Martin A., Portaels F., and Palomino J.C. Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J. Antimicrob. Chemother. 59 (2007) 175-183
18. McCoy M.H., and Wang E. Use of electric cell-substrate impedance sensing as a tool for quantifying cytopathic effect in Influenza A virus infected MDCK cells in real-time. J. Virol. Methods 130 (2005) 157-161
19. Nichol K.L., et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 282 (1999) 137-144
20. Noah J.W., Severson W., Noah D.L., Rasmussen L., White E.L., and Jonsson C.B. A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals. Antiviral Res. 73 (2007) 50-59
21. O'Brien J., Wilson I., Orton T., and Pognan F. Investigation of the Alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267 (2000) 5421-5426
22. Ryan-Poirier K., Katz J., Webster R., and Kawaoka Y. Application of directigen FLU-A for the detection of Influenza A virus in human and nonhuman specimens. J. Clin. Microbiol. 30 (1992) 1072-1075
23. Sidwell R.W., and Huffman J.H. Use of disposable microtissue culture plates in antiviral and interferon induction studies. Appl. Microbiol. 22 (1971) 797-801
24. Sidwell R.W., and Smee D.F. In vitro and in vivo assay systems for study of influenza virus inhibitors. Antiviral Res. 48 (2000) 1-16
25. Smee D.F., Morrison A.C., Barnard D.L., and Sidwell R.W. Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. J. Virol. Methods 106 (2002) 71-79
26. Suguitan A.L., McAuliffe J., Mills K.L., Jin H., Duke G., Lu B., Luke C.J., Murphy B., Swayne D.E., Kemble G., and Subbarao K. Live, attenuated Influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med. 3 (2006) 1541-1555
27. Vanitha J.D., and Paramasivan C.N. Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates. Diag. Microbiol. Infectious Dis. 49 (2004) 179-182
28. Wardlaw A.C. Practical Statistics for Experimental Biologists (1985), John Wiley and Sons, Toronto